Global supply chain turmoil threatens India’s role as the “Pharmacy of the World,” with medicine prices rising and export lifelines under siege. India’s pharmaceutical exports, valued at USD 30.47 billion in FY25, are staring at a potential loss of USD 300–500 million (₹2,500–₹4,500 crore) as
Recent Posts
- Where Is Gyanesh Kumar Now? The Constitutional Eclipse at Nirvachan Sadan
- India’s 10 Core Economic Engines: An Empirical Breakdown of Growth, Jobs, Trade, and FDI
- The Growth Arithmetic vs. Ground Realities: India’s Macro Balance Sheet Needs More Than Sectoral Triumphalism
- India’s BRICS Chairship Delivers Consensus Amid Fractures: Practical Gains, Measured Diplomacy, and Limits of Alignment
- The 3-Paise Settlement: How India’s Financial Architecture Capitulated to Subhash Chandra’s ₹22,000-Crore Default










